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Phosphorylation of the C-terminal 
tail of proteasome subunit α7 
is required for binding of the 
proteasome quality control  
factor Ecm29
Prashant S. Wani1, Anjana Suppahia2, Xavier Capalla2, Alex Ondracek2 & Jeroen Roelofs1,2
The proteasome degrades many short-lived proteins that are labeled with an ubiquitin chain. The 
identification of phosphorylation sites on the proteasome subunits suggests that degradation of these 
substrates can also be regulated at the proteasome. In yeast and humans, the unstructured C-terminal 
region of α7 contains an acidic patch with serine residues that are phosphorylated. Although these 
were identified more than a decade ago, the molecular implications of α7 phosphorylation have 
remained unknown. Here, we showed that yeast Ecm29, a protein involved in proteasome quality 
control, requires the phosphorylated tail of α7 for its association with proteasomes. This is the first 
example of proteasome phosphorylation dependent binding of a proteasome regulatory factor. Ecm29 
is known to inhibit proteasomes and is often found enriched on mutant proteasomes. We showed 
that the ability of Ecm29 to bind to mutant proteasomes requires the α7 tail binding site, besides a 
previously characterized Rpt5 binding site. The need for these two binding sites, which are on different 
proteasome subcomplexes, explains the specificity of Ecm29 for proteasome holoenzymes. We propose 
that alterations in the relative position of these two sites in different conformations of the proteasome 
provides Ecm29 the ability to preferentially bind specific proteasome conformations.
The ubiquitin proteasome system (UPS) is present in all eukaryotes and enables cells to degrade many proteins 
in a highly regulated fashion1. Numerous enzymes are required to specifically label proteins that are destined for 
degradation with ubiquitin. Ubiquitin, a short polypeptide, is normally covalently attached to lysine residues 
present in the target protein. The ubiquitinated proteins become substrates for the proteasome, a 2.5 MDa pro-
tease complex. The proteasome holoenzyme consists of 33 unique polypeptides that are assembled into two main 
subcomplexes: the regulatory particle (RP) and the core particle (CP). The RP recognizes ubiquitinated substrates 
either through direct interaction with proteasome subunits that function as ubiquitin receptors, like Rpn10, 
Rpn13, or Rpn1, or through recognition of adaptors that bind ubiquitinated substrates and the proteasome, such 
as Rad23 or Dsk22,3. The RP removes the ubiquitin from substrates and unfolds them. The unfolding occurs at 
an AAA-ATPase ring formed by the six homologous proteasome subunits Rpt1 to Rpt6. The Rpt ring abuts the 
CP and is responsible for threading substrates into the CP where the proteolytic active sites are located. The CP 
is formed by four hetero-heptameric rings that are stacked upon one another, resulting in a hollow, cylinder-like 
structure. CP subunits are of two types, α and β , arranged to form an α 1–7β 1–7β 1–7α 1–7 structure. β 1, β 2, and β 5 are 
the catalytic subunits that provide the protease activity required for protein degradation.
The proteasome is an abundant complex in the cell, therefore it is important for the cell to assemble all 66 
subunits that comprise this RP2-CP complex efficiently and correctly. To achieve this, proteasome assembly is 
tightly orchestrated in the cell with the help of ten dedicated assembly chaperones4,5. Five of these chaperones, 
Hsm3, Nas2, Nas6, Rpn14, and Adc17, are dedicated to RP assembly. The other five chaperones, Pba1, Pba2, Pba3, 
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Pba4, and Ump1, assist in CP assembly. Interestingly, these chaperones not only promote the formation of specific 
subcomplexes, but several also prevent the premature association of RP and CP. For example, the CP chaperones 
Pba1-Pba2 prevent the association of RP with immature CP6,7. Similarly, the RP chaperones are capable of block-
ing mature CP from interacting with RP8–11. Thus, it appears that the final step in assembly, the association of CP 
with RP, is tightly controlled.
The chaperones, under normal conditions, only bind to proteasome subcomplexes and are not found on the 
holoenzyme or mature CP. Several other proteasome-associated components have been identified that have bind-
ing sites on either CP or RP12. However, these have also been found associated with 26S proteasomes or mature 
CP, suggesting they regulate proteasome activity or assist in proteasome function. Indeed, several assist in deliv-
ery of substrates to the proteasome, modify the ubiquitin chains on substrates, or change the hydrolytic activity of 
the core particle12. Ecm29 is a unique proteasome component as it is the only one known to bind to the RP (Rpt5) 
as well as the CP13,14. Nevertheless, it is normally only found on singly and doubly capped proteasomes, i.e. RP-CP 
complexes and RP2-CP complexes13,15.
Ecm29 is a large protein (210 kDa) predicted to contain 29 HEAT repeats. Both CryoEM analyses and struc-
ture predictions of Ecm29 suggest that Ecm29 forms an elongated and curved protein similar to many other 
proteins with multiple HEAT repeats13,16. Several functions have been proposed for yeast Ecm29 and the human 
ortholog KIAA0368. For example, it has been suggested to remodel proteasomes under stress conditions17,18, 
as well as play a role in localizing proteasomes to membrane components19–21, or movement of proteasomes in 
neurons22. Initially, it was thought to positively regulate proteasome function as it stabilizes the RP-CP interac-
tion in the absence of nucleotide13,15. However, Ecm29 has been shown to inhibit proteasome activity in vivo and 
in vitro14,23.
The inhibition by Ecm29 involves two mechanisms: first, Ecm29 binding induces closure of the substrate 
entry channel17,23. This channel is found on the top and bottom of CP and is normally opened by RP. Second, 
Ecm29 reduces the ATPase activity of proteasomes. This ATPase activity is required to unfold substrates so that 
they can enter the CP14. Interestingly, Ecm29 has been found enriched on a variety of proteasome mutants17,23–25. 
These and other data led to the proposed function of Ecm29 as a quality control factor that recognizes aberrant 
proteasomes14,23–25.
It remains poorly understood why Ecm29 is enriched on mutant proteasomes. Ecm29 could specifically rec-
ognize faulty proteasomes14, it could be an unstable proteasome substrate that is stabilized resulting from reduced 
proteasome activity24,25, or it could be upregulated in strains with proteasome mutations17. To better understand 
how Ecm29 associates with the proteasome and regulates proteasome activity, it is crucial to understand where 
Ecm29 binds to the proteasome complex. Using a crosslinking approach, we previously identified the RP subunit 
Rpt5 as an interaction partner of Ecm2914. However, no CP subunits were identified.
Here, we report the identification of an Ecm29 binding site on the core particle subunit α 7. Truncation of 
the C-terminal tail of α 7 substantially diminishes the Ecm29 interaction with the proteasome in both wild type 
and in mutant proteasomes. Phenotypic analyses confirm that this tail of α 7 is important for Ecm29 binding to 
proteasomes in vivo as well. Interestingly, the tail of α 7 has a conserved acidic region that contains three serine 
residues that are known to be phosphorylated. Mutation of these sites indicates that Ecm29 depends on α 7 phos-
phorylation for its interaction with the CP. Thus, our data reveal an additional level of complexity to the binding 
of Ecm29 to proteasomes and identify a function for the phosphorylation sites in the tail of α 7.
Results
α7 subunit of CP as putative binding partner for Ecm29. Ecm29 is predicted to bind CP as well as 
RP13. Based on the large size and predicted elongated and curved structure13,16, we hypothesized Ecm29 binds 
CP in close proximity to RP binding site Rpt514. Recent mapping of the RP-CP interaction and structural insights 
from several cryoEM structures of the proteasome provide a detailed understanding of the location of Rpt5 with 
respect to CP26–29 (Fig. 1a). The C-terminus of Rpt5 docks into a pocket formed at the interface of the CP subunits 
α 5 and α 626–29 and has also been shown to be able to occupy the pocket between α 6 and α 726. The face of the CP 
cylinder provides the principal interaction surface with the RP. Here, the α -subunits have N-termini that extend 
and contribute to the formation of the CP gate30. This area is unlikely to be available for Ecm29 binding, because 
it is covered by the RP in the 26S proteasomes27–29. Thus, Ecm29 is more likely to bind to the lateral surfaces of α 
-subunits. Interestingly, four out of seven α -subunits (α 3, α 4, α 5, and α 7) have C-terminal amino acid sequences 
(≥ 10 residues) that are not resolved in the crystal structure of the CP and are likely to extend from the lateral 
surface of the CP30. Of these, α 7 contains the longest extension, 40 residues, and this tail contains a patch of acidic 
amino acids (Fig. 1b). Human α 7 has a similar C-terminal tail that extends beyond the crystal structure and 
harbors numerous acidic residues31 (Fig. 1c). Thus, features of the α 7C-terminal tail are conserved from yeast to 
human. Since Ecm29 is conserved, presumably the binding site is as well. Figure 1a shows the last three resolved 
α 7 residues in a 26S model in red. From this it is clear that the extended tail is in close proximity to the subunit 
that binds Ecm29 (Rpt5, light blue in Fig. 1a) .
C-terminal tail of α7 subunit is important for Ecm29 binding to the proteasome. To test if the 
α 7 C-terminal tail is important for Ecm29-proteasome interaction, we deleted the last 40 amino acid residues 
from the α 7 subunit (Fig. 2a). These are residues that were not resolved in the crystal structure of the CP30. Strains 
with this α 7 truncation were viable and we refer to the truncation as α 7-Δ 40 from here onwards. To purify pro-
teasomes we introduced this truncation into strains that either contained the protein A-tagged RP subunit Rpn11 
or protein A-tagged CP subunit Pre1 (β 4)13.
Compared with wild type proteasomes, proteasomes purified from these strains showed a similar pattern on 
Coomassie Brilliant Blue (CBB) stained SDS-PAGE gels (Fig. 2b). Immunoblotting for α 7 showed a lower molec-
ular weight for α 7 upon truncation, consistent with the expected reduction in molecular weight from 31.5 kD to 
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27.3 kD. Purified proteasomes also showed a strongly reduced level of Ecm29 upon truncation of α 7 (Fig. 2b). 
As is evident from the protein staining, proteasome preparations purified using the CP-tag have generally reduced 
levels of RP co-purified and increased amounts of CP as compared to RP-based proteasome purifications. This 
tag-induced difference likely explains the lower levels of Ecm29 in CP-tag proteasome purifications as compared 
to RP-tag preparations. However, there is consistently a clear reduction of Ecm29 levels upon deletion of the 
α 7 tail.
Native gel analyses of proteasome complexes purified from wild type and α 7-Δ 40 strains also showed reduced 
levels of Ecm29 in the α 7-Δ 40 background. The small amount of Ecm29 that is still bound to proteasomes binds to 
the same complexes as has been observed under wild type conditions (Fig. 2c). Additionally, we observed a slower 
migrating form of CP in the α 7-Δ 40 samples. A similar slower migration of CP is observed when CP associates 
with the CP interacting protein Blm1032. However, we did not observe increased levels of Blm10 in α 7-Δ 40  
proteasomes compared to wild type proteasomes (Fig. 2b). The α 7 truncation contains 16 acidic residues and 
the calculated isoelectric point (pI) of the protein changes from 5.0 to 7.7, thus instead of other proteins binding 
to CP, the altered migration might be a consequence of the difference in charge between wild type and α 7-Δ 40 
CP. To test this we purified CP from wild type as well as from α 7-Δ 40 (Fig. 2d). The high salt washes required to 
purify CP also removed any Blm10 that might be bound to the CP, as is apparent from the absence of ~240 kDa 
bands in CP preparations (Fig. 2d). Even in the absence of Blm10, α 7-Δ 40 derived CP showed a retarded migra-
tion compared to CP with full-length α 7. Thus, the change in migration results from the truncation and is most 
likely due to the loss of negatively charged amino acid residues. In sum, our data show that truncation of the α 7 
tail led to reduced binding of Ecm29 to proteasome.
Effect of α7 C-terminal tail truncation in vivo. Next, in order to determine the physiological importance 
of the α 7 truncation in vivo, we analyzed cells for two phenotypes typical for proteasome mutants: sensitivity to 
heat stress at 37 °C and canavanine sensitivity. Both of these conditions are thought to introduce protein misfolding 
stress due to the high temperature or the incorporation of the arginine analog canvanine. Unlike several 
proteasome mutants or mutants with defects in proteasome assembly, the α 7 truncation did not cause increased 
sensitivity to these conditions (Fig. 3a,b). This suggests there are no major defects in proteasome function 
upon deletion of the α 7C-terminal tail. Similarly, the deletion of Ecm29 by itself does not cause temperature 
sensitivity or canavavine sensitivity.
Next, we tested if the truncation can rescue or cause synergistic effects in backgrounds where this has been 
observed for the deletion of Ecm29. Here, we predict that strains with the α 7C-terminal truncation should, at 
least in part, mimic phenotypes that resulted from a deletion of ECM29 in sensitized backgrounds, because 
α 7-Δ 40 results in reduced binding of Ecm29 to proteasome. We have previously characterized the rpt5-Δ 3 
mutant where the last three amino acids of the Rpt5 subunit are absent. In this strain proteasomes are enriched in 
Ecm2923. The Rpt5 residues that are missing in rpt5-Δ 3 strains are involved in the docking of RP onto CP33–36. The 
rpt5-Δ 3 strain shows canavanine sensitivity resulting from the cumulative effect of reduced proteasome activity 
caused by the mutant form of Rpt5 as well as the inhibition by Ecm2914. The canavinine sensitivity can be rescued 
by a deletion of ECM29. When we introduced the α 7 tail truncation in rpt5-Δ 3 strains, the canavanine sensitivity 
was also rescued. Thus, the truncation of the α 7 tail phenotypically mimics the deletion of ECM29.
The deletion of the assembly chaperone UMP1 results in an enrichment of Ecm29 on proteasomes and the 
deletion of Ecm29 in an ump1Δ background causes increased sensitivity at 37 °C24. The α 7C-terminal trun-
cation in ump1Δ causes increased sensitivity at 37 °C as well (Fig. 3a), indicating the deletion of the 40 amino 
Figure 1. α7 as the putative binding site for Ecm29. (a) CryoEM-based model of the Proteasome29 (PDB- 
4B4T) showing regulatory particle (RP) and core particle (CP). Rpt5 is displayed in cyan and other Rpt subunits 
in blue. Lid subunits Rpn5 and Rpn6 that interact with the CP are shown in purple and the remainder of RP is 
shown in green. The core particle α subunits are colored in yellow, with the last three ordered amino acids of  
α 7 shwon in red. β subunits are colored in orange. (b) Amino acids sequences from the α -ring subunits beyond 
crystal structure30 and model presented29. Second column shows the last three ordered amino acids for each 
α subunit. Third column shows C-terminal amino acids that were not resolved in the structure. Consecutive 
acidic residues in C-terminal of α 7 residues that forms the acidic patch are underlined as red line. (c) Sequence 
alignment of acidic patch in the C-terminal tail of α 7 from S. cerevisiae and H. sapiens.
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acids from the α 7 causes a phenotype similar to the deletion of Ecm29 in this background as well. The deletion 
of Ecm29 or the α 7C-terminal truncation does, however, not rescue the canavanine sensitivity of ump1Δ cells 
(Supplementary Figure 1). This might not be surprising considering the important role of Ump1 plays in assembly 
of the CP. In sum, the α 7 truncation phenotypically mimics a deletion of Ecm29 in strains where ecm29Δ changes 
the phenotype of the strain (rpt5-Δ 3 and ump1Δ ), consistent with our in vitro observations that the α 7 tail is 
important for the binding of Ecm29 to proteasomes.
Next, we biochemically characterized proteasome complexes formed in the mutant strain background. Cell 
lysates were resolved on native gels followed by activity assays using the fluorogenic peptide LLVY-AMC (Fig. 3c). 
Singly and doubly capped proteasomes can associate with Ecm29. This association causes a slower migration on 
native gel13,15. Blm10 binding can also cause a slower migration, but only for singly capped proteasomes. However, 
our native gel analyses in the presence or absence of Blm10 indicates that the Blm10-containing species do not 
play a major role in the assays discussed below (Supplementary Figs 2 and 3). Rpt5-Δ 3 cells are highly enriched in 
Ecm29 as compared to wild type cells. Consequently, rpt5-Δ 3 proteasomes show a notably slower migrating spe-
cies on the native gel, caused by association with Ecm29 as it is absent from ecm29Δ cells (Fig. 3c compare lane 
3 and 5). Consistent with our phenotypic data, truncations of α 7 in the rpt5-Δ 3 background caused a migration 
of the proteasomes on native gels similar to that resulting from the deletion of ECM29. This indicates a reduced 
recruitment of Ecm29 to α 7-Δ 40 rpt5-Δ 3 proteasomes.
To analyze the level of Ecm29 present in the different strains we ran the same samples on SDS-PAGE and con-
ducted immuno blot analyses using an antibody that can recognize the endogenous Ecm29 protein (Fig. 3c lower 
Figure 2. The C-terminal tail of the α7 is required for the binding of Ecm29 to the proteasome.  
(a) Schematic representation of wild type α 7 displaying the acidic patch (residues D250 to D259) and the α 
7 with C-terminal truncation (α 7-Δ 40) that removes all amino acids beyond N248. (b) Proteasomes were 
purified from wild type and α 7-Δ 40 cells using either an RP tag (Rpn11- TEV-ProA; left panel) or CP tag (Pre1-
TEV-ProA; right panel) and analyzed on SDS-PAGE as well as by immunoblotting using antibodies against 
Ecm29 and α 7. (c) RP-tag derived proteasome purifications from (b) were resolved on native gel and stained 
using an in-gel activity assay with LLVY-AMC as substrate in the presence of 0.02% SDS. Gel was coomassie 
stained or transferred to pvdf membrane to probe for the presence of Ecm29 and α 7. (d) CP from wild type and 
α 7-Δ 40 cells was resolved on SDS-PAGE and stained with CBB (left panel). Same samples were also resolved 
on native gel, followed by in-gel LLVY-AMC activity assay and CBB staining. Difference in electrophoretic 
migration of CP from α 7-Δ 40 does not results from an enrichment in Blm10 and is likely due to the difference 
in charge between α 7 and α 7-Δ 40.
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panel). As observed previously, the rpt5-Δ 3 strain shows increased levels of Ecm29 in total cell lysate compared to 
wild type. Furthermore, truncation of α 7 in this background reduces the levels of Ecm29 back to levels similar to 
wild type (Fig. 3c, compare lane 1, 3, and 6). Ecm29 has been reported to be degraded by proteasomes24,25, which 
might suggest that a loss of interaction with proteasomes increases Ecm29 turnover. However, other reports have 
suggested Ecm29 is stable and increased levels on proteasomes result from higher rates of transcription17. This 
would suggest the α 7 tail truncation results in a lower level of Ecm29 expression in α 7-Δ 40 mutant strains. In 
either case, the effect of the truncation of α 7 seems to be background dependent, as in both the ump1Δ and the 
ump1Δ α 7-Δ 40, Ecm29 levels are increased as compared to wild type.
To eliminate complications in our analysis as a result of differences in transcriptional regulation of ECM29, we 
exchanged the promoter of ECM29 with the GPD promoter. For wild type cells this has been previously shown 
to increase the levels of Ecm29 in the cell and result in stoichiometric amounts of Ecm29 on proteasomes14,17 
(Fig. 4a,b). Under these conditions we see high levels of Ecm29 in the cell lysate of both wild type and α 7-Δ 40 
cells. Native gel analyses, however, clearly shows a reduced level of Ecm29 on 26S proteasomes from the α 7-Δ 40 
strains, with singly capped proteasomes having hardly any Ecm29 associated with the proteasome and strongly 
reduced amount of doubly capped proteasomes associated with Ecm29. Thus, even under conditions of very 
strong overexpression of Ecm29 the truncation of α 7 causes reduced binding of Ecm29 to proteasomes. Since 
Ecm29 binds to Rpt5 in addition to α 7, the lost of α 7 binding probably results in a substantially reduced affinity 
of Ecm29 for proteasomes, but may not invoke a complete loss of binding. This can explain some limited binding 
of Ecm29 to proteasomes in the α 7-Δ 40 background.
The ability to drive Ecm29 association with the proteasome by increasing the levels of Ecm29 in the cell sug-
gests that Ecm29 association with proteasomes is driven by the transcriptional regulation of ECM29 in the cell. 
However, we have previously shown that Ecm29 shows better binding to mutant proteasomes as compared to 
wild type proteasomes14. Thus, an alternative explanation for the observation of Ecm29 on wild type proteasomes 
Figure 3. The α7 C-terminal tail is important for Ecm29 proteasomal association in vivo. (a,b) Indicated 
strains were serially diluted (four-fold) and (a) spotted onto YPD medium and grown at the indicated 
temperatures for 3 days or (b) spotted on SD plates lacking arginine with or without canvanine and grown at 
30 °C for 5 to 6 days. The α 7-Δ 40 truncation resemble a deletion of ECM29 in the different backgrounds.  
(c) Equal protein amount of total cell lysates from the indicated strains were analyzed on 3.5% nondenaturing 
gel and stained using the LLVY-AMC activity assay (upper panel). Protein extracts were also resolved on SDS-
PAGE, followed by immuno blotting to determine the levels Ecm29 and Rpn8. Immunoblot against Pgk1 was 
used as a loading control.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:27873 | DOI: 10.1038/srep27873
is that a lower affinity of Ecm29 for wild type proteasomes can be obscured by strong overexpression of Ecm29. 
Ecm29 levels resulting from GPD promoter are for example substantially higher than any increase resulting from 
upregulation of the endogenous locus through the stabilization of Rpn4. Thus, analyses from GPD promoter 
driven Ecm29 overexpression results are non-physiological. Therefore, we created strains where Ecm29 expres-
sion is not driven by the very strong GPD promoter, but by the much weaker ADH promoter (Fig. 4c,d). Here, 
we still eliminate the Rpn4 feedback loop by replacing the endogenous promoter, but now have a much lower 
transcription level of ECM29. Consistent with this, there is less Ecm29 in the cells as compared to wildtype cells 
(Fig. 4c). That notwithstanding, the level of Ecm29 in the cell and on the proteasome dramatically increase in 
rpt5-Δ 3 cells with the ADH promoter. These cells very much resemble our observations made in rpt5-Δ 3 cells 
which have the endogenous promoter. Thus, Rpn4 driven transcriptional upregulation is not required to achieve 
increased association of Ecm29 with mutant proteasomes.
α7 phosphorylation is required for Ecm29 interaction with CP. Seven phosphorylation sites have 
been identified in yeast α 737–43. Interestingly, five of these sites, S258, S263, S264, T278 and T279, are present in 
the tail of the α 7 that we eliminated. From these, S258, S263, and S264 have been identified multiple times and 
also in studies specifically focused on phosphorylation of the proteasome37,39,40,43. The phosphorylation of α 7 has 
been observed in humans as well, suggesting there is a conserved function for this modification44–46. CK2 (for-
merly known as casein kinase 2) has been proposed to be responsible for phosphorylation of the serine residues 
present with the α 7C-terminal tail37,47. CK2 generally phosphorylates serine residues in an acidic environment48, 
which is provided by the acid patch present in the α 7 tail. Furthermore, the phosphorylation by CK2 is often 
constitutive. This is consistent with the observation that yeast as well as human α 7 is present almost exclusively 
in the phosphorylated form43. To test if α 7 is phosphorylated under our conditions, we purified proteasomes 
and resolved preparations on SDS-PAGE. Gels were stained with CBB and analyzed using the in-gel pro-Q dia-
mond phosphostain. These analyses show a band corresponding to the size of α 7 that is strongly phosphorylated. 
Consistent with our assignment of α 7, this band disappears in the phospho-stain analyses when analyzing protea-
somes from the α 7-Δ 40 strain (Fig. 5c, right panel). Since no band of lower molecular weight appeared, our data 
show that α 7 is mainly phosphorylated in the C-terminal fragment, as recently suggested43. To test if T278 and 
T289 in α 7 are essential for the ability of Ecm29 to bind proteasomes, we eliminated these phosphorylation sites 
by making a truncation that removes only 19 residues instead of 40 from α 7, keeping the acidic patch and three 
serine phosphorylation sites intact, namely S258, S263, and S264. We refer to this mutant as α 7-Δ 19 (Fig. 5a). 
Ecm29 is detectable in these strains (Fig. 5b). Proteasomes purified from an α 7-Δ 19 strain showed a band of 
the expected size on a phospho-stain gel, indicating that the remaining phosphorylation sites are still phospho-
rylated (Fig. 5c). The levels of Ecm29, as determined by immunobotting, are similar to those of Ecm29 found 
associated with wild type proteasome (Fig. 5c). Thus, Ecm29 binding is mediated by the fragment of the α 7 tail 
that contains the acidic patch and the serine phosphorylation sites. To test the importance of phosphorylation of 
Figure 4. Exchange of Ecm29 promoter to eliminate differential transcription of Ecm29. (a,b) The 
endogenous promoter of Ecm29 was replaced with the GPD promoter. This exchange causes a strong 
overexpression of Ecm29 that drives binding of Ecm29 to all most all wild type proteasomes14,17, as is seen in 
the immunoblot of total lysates. Native gel analyses of total lysate can visualize presence of Ecm29 on singly and 
doubly capped proteasomes because the presence of Ecm29 causes a migrational shift. The presence was also 
confirmed by immunoblotting the native gel and probing with an anti-Ecm29 antibody. Even under conditions 
of strong overexpression the α 7-Δ 40 strain shows strongly reduced levels of Ecm29 on singly and doubly 
capped proteasomes. (c,d) The endogenous promoter of Ecm29 was replaced with the ADH promoter resulting 
in weak expression of Ecm29 in wild type as well as in rpt5-Δ 3 strain background. Analyses were identical as for 
(a,b). With weak promoter the behavior of Ecm29 in wildtype and mutant strains is very similar to cells with the 
endogenous promoter, suggesting the Rpn4-dependent transcriptional regulation of Ecm29 is not essential for 
the enrichment of Ecm29 on proteasomes.
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these serine residues, we introduced serine to alanine mutations into the α 7-Δ 19 background. The strains with 
all three serine residues mutated to alanine (S258A, S263A, S264A) is referred to as α 7-Δ 19 (S/A). Proteasomes 
purified from α 7-Δ 19 (S/A) cells showed no detectable phosphorylation of α 7 in our phospho-stained gel assay 
(Fig. 5c). Interestingly, these proteasomes showed dramatic reduction in the amount of Ecm29, having levels 
similar to those on α 7-Δ 40 derived proteasomes. Consistent with an important role for serine phosphorylation 
in the binding, mutations of the serine residues to aspartate retained normal levels of Ecm29 on the proteasomes 
(supplementary Fig. 4). Thus, the binding of Ecm29 to proteasomes requires the phosphorylation at serine resi-
dues in the tail of α 7.
It is currently unclear if the binding of Ecm29 to mutant proteasomes relies on fundamentally different protea-
some binding sites or if Ecm29 utilizes the same binding sites for binding to wild type and mutant proteasomes. 
To test this for the phsophorylated α 7 tail, we introduced the α 7-Δ 19 (S/A) mutant in the rpt5-Δ 3 background. 
Upon purification of proteasomes we observed that mutation of the serines in the rpt5-Δ 3 background still leads 
to reduced levels of Ecm29 on proteasomes. Thus, the recruitment of Ecm29 to faulty proteasomes relies on the 
ability of Ecm29 to bind to CP as well as RP.
Discussion
Many sites of post-translational modification have been identified on the proteasome49. Some functions for 
proteasome phosphorylation have been described, like enhanced degradation of substrates50–53, regulation of 
proteasome activity in particular compartments54, or regulation of proteasome assembly or stability55. While 
the mechanisms are often unclear, the phosphorylated residues of proteasome subunits have been proposed to 
(directly) regulate the proteasomal ATPase activity, state of the CP gate, or the proteolytic active sites. Here, we 
report that the phosphorylated tail of α 7 is important for binding of the proteasome-associated factor Ecm29. 
While it has been suggested that phosphorylation of the α 7 tail might leads to a conformational change in RP 
Figure 5. Binding of Ecm29 to proteasomes depends on the phosphorylation of the C-terminal tail of α7. 
(a) Schematic overview of α 7 truncations and mutations used. A shorter truncation of the α 7 C-terminal tail,  
α 7-Δ 19 (1–269), was created. This truncation retains the acidic patch as well as three serine phosphorylation 
sites (S258, S263 and S264). Mutation of these phosphorylation sites to alanine in this background resulted 
in the α 7-Δ 19 (S/A) strain. (b) Ecm29 levels in indicated strains was analyzed by immunoblotting of whole 
cell lysates using the anti-Ecm29 antibody and an anti-Pgk1 antibody as loading control. (c,d) Proteasome 
complexes were purified from the indicated strains and equal amount of purified proteasomes were analyzed 
on the SDS-PAGE and Coomassie Blue stained or used for immunoblotting to determine level of Ecm29. 
Immublots against α 7 were used to confirm truncations and immunoblots agains Rpn8 served as loading 
control. To determine phosphorylation state, samples resolved by SDS-PAGE were stained with Pro-Q Diamond 
Phosphoprotein Gel Staining assay (right panels).
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or CP49, we think this is unlikely based on our data and recent published work43 and propose a direct binding of 
Ecm29 to the α 7 tail. Irrespectively, this is the first example where the association of a proteasome interacting 
proteins depends on a phosphorylated proteasome subunit.
Often phosphorylation is a transient modification that has a local effect for a limited period of time and affects 
only a subset of a particular protein. Both in humans and yeast, however, the phosphorylation of the proteasome 
α 7 subunit appears to be constitutive, readily detectable, and present on > 95% of the α 7 subunits43. Ecm29, on 
the other hand, is only found on a subpopulation of proteasomes, suggesting that the phosphorylation of α 7 is not 
the distinguishing factor that determines which proteasomes bind Ecm29. Instead of being a trigger that creates 
a binding site for Ecm29, α 7 phosphorylation appears to provide a pre-requisite for binding. Consistent with 
this model, the kinase that likely phosphorylates α 7, CK2, is a constitutive kinase with many substrates in the 
cell37,47,48. CK2 phosphorylation has for example also been proposed to be a prerequisite for the UBC3 binding to 
the F-box receptor β -TrCP56. To identify functions of α 7 phosphorylation it will be crucial to identify a cellular 
condition where the phosphorylation is reduced. Immature CP could be one such condition, considering Ecm29 
is normally only found on mature assembled proteasomes. However, in immature CP α 7 is already phosphoryl-
ated (Supplementary Figure 5a). An alternative to identify functions of α 7 phosphorylation is the identification 
of a phosphatase responsible for the removal of the phospho-groups can provide valuable insight. An important 
role for a phosphatase in regulating proteasome function has been reported previously, with UBLCP1 regulating 
nuclear proteasomes54, but no yeast ortholog of this phosphatase exists.
The phosphorylation of the α 7 tail is important for association of Ecm29 with proteasomes, but it remains 
unclear if that is the only function of the phosphorylated tail of α 7. Previous studies have reported that in humans 
the phosphorylation of α 7 is important for regulating the stability of the CP-RP interactions46, but this was not 
linked to Ecm29. Ecm29-dependent stabilization of CP-RP is particularly striking in the absence of nucleotide, 
where yeast proteasomes would dissociate otherwise. In the absence of Ecm29 a similar stabilization can be 
achieved by treating proteasomes with proteasome inhibitors15. However, this stabilization does not depend on 
the tail of α 7 (Supplementary Figure 5b). Thus, it remains to be determined if α 7 can stabilize CP-RP directly as 
well as through Ecm29.
The α 7 tail might also serve to bind or recruit other factors besides Ecm29. Several proteins have been reported 
to bind to α 7, including several ubiquitin-independent proteasome substrates57,58. The role of the C-terminal tail 
here remains to be clarified.
As predicted during the initial identification of Ecm29 as a proteasome associated protein in 2001, and val-
idated herein, Ecm29 binds to both RP and CP13,14. The identification of these sites provides an important clue 
towards the mechanism of Ecm29 recruitment to specific proteasomes subpopulations. Nevertheless, we do not 
fully understand why Ecm29 is present in substoichiometric amounts on wild type proteasomes, but is highly 
enriched on a variety of proteasome mutants. Ecm29 does not appear to compensate for defects by stabilizing 
proteasomes, but instead to specifically bind and inhibit mutant proteasomes14,17,23. Phenotypically, the effect of 
deleting Ecm29 is rather pleiotropic, suggesting it has multiple functions in the cell or becomes a dominant nega-
tive factor under certain conditions. Either way, the mechanisms responsible for enrichment of Ecm29 on mutant 
proteasomes are still poorly understood.
Three models have been put forward to explain enrichment of Ecm29 on mutant proteasomes: first, 
Rpn4-dependent enrichment17. In this model, reduced proteasome activity as a result of a mutation in proteas-
ome subunits leads to the accumulation of the unstable transcription factor Rpn459. Rpn4 recognizes the PACE 
element found in the promoter of Ecm29 as well as many proteasome subunit60. As a result, both proteasome sub-
units and Ecm29 are upregulated. However, Ecm29 upregulation is stronger, thereby causing a relative increase in 
Ecm29 as compared to proteasomes17. Since we observed Ecm29 enrichment on mutant proteasomes in strains 
where the endogenous promoter was replaced with the ADH promoter (Fig. 4c), it is clear that this mechanism is 
not solely responsible for proteasomal enrichment of Ecm29. That said, it probably is an important contributing 
factor and other type of proteasome mutants might rely more heavily on this mechanism.
The second model proposes a high affinity of Ecm29 for mutant proteasomes14. This model is consistent with 
our observation that strong overexpression of Ecm29 can compensate for a weaker affinity and drive proteasomal 
binding of Ecm29 to normal proteasomes. However, weaker promoters, like the ADH promoter, prevent this and 
thus result in an almost exclusive accumulation of Ecm29 on mutant proteasomes. Although we lack the molec-
ular insight into a mechanism that would allow for such a difference in affinity, it might involve differences in the 
relative position of the Ecm29 binding sites on CP relative to RP.
The interaction between CP and RP has some flexibility as the tails of the Rpt5 has been found to interact 
with CP at different positions26. Furthermore, analyses of the different cryoEM structures of the proteasome has 
revealed differences in the CP-RP interface that are probably linked to the nucleotide status of the ATPases61,62. 
Using, three states with reported PDB structures61 (S1, a ground state; S2, an intermediate state; S3 an activated, 
ATPγ S-bound, state) we aligned the α 7 subunit to reveal difference in relative position of Rpt5 compared to α 7. 
We noticed substantial differences in the Rpt5 position (Fig. 6). For example, the distance between α 7 I246 and 
Rpt5 D209 changes from 32.4 Å in the S1 state to 42.3 Å in the S3 state. This likely indicates the relative position 
of the two binding surfaces Ecm29 uses to interact with the proteasome changes depending on the proteasome 
conformation. Such changes could explain differences in binding affinity of Ecm29 for particular proteasome 
conformations. Consistent with this model, it has been proposed that Ecm29 might bind or trap proteasomes 
in the S1 state3, thereby inhibiting proteasomal ATPase activity. Enrichment of Ecm29 on proteasome mutants 
could then be a result of increased occupation of a ground state by these mutant proteasomes. However, the 
majority of wildtype proteasomes, at least in neurons, appears to be in a ground state63. So, there might be as of yet 
uncharacterized states of the proteasome that Ecm29 has high affinity for. This idea is supported by observations 
that Ecm29 bound proteasomes have a closed gate, something not observed in the S1 state14,17,23. Furthermore, 
proteasomes depleted for nucleotides, a condition that leads to RP-CP dissociation and thus is different from 
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S1, show increased Ecm29 binding and Ecm29-dependent stabilization of RP-CP14,15. Since, many mutants that 
accumulate Ecm29 are linked to deficiencies in RP-CP interactions, direct or indirectly, these could accumulate 
a different proteasome state12,20,21,31.
Alternatively, a higher affinity of Ecm29 to proteasomes could be induced by local changes in the structure, 
for example if a mutation of the Rpt5 subunit changes the shape directly or through the nucleotide occupancy of 
Rpt5. However, the enrichment of Ecm29 on Rpt5-Δ 3 proteasomes still depends on the ability of Ecm29 to bind 
to the phosphorylated α 7 tail.
The third model is based on differences in Ecm29 degradation. This model proposes that Ecm29 is degraded 
by the proteasome. Hence, any defects in proteasome function result in stabilization of Ecm29 and a subsequent 
enrichment of Ecm29 on proteasomes. While this model is simple and elegant, our observations that Ecm29 
inhibits proteasomes suggests Ecm29 would prevent its own degradation. Tagged versions of Ecm29 have been 
reported to be degraded24,25 and degradations rates could also be influenced by internal disordered regions 
are more or less accessible for engagement by the proteasome, like has been shown for other substrates64. Less 
availability of such regions when Ecm29 binds mutant proteasomes could dramatically change protein half-life. 
However, endogenous Ecm29 has been reported to be stable17, leaving little support for this model.
In sum, our data show that phospohorylation of the tail of α 7 is a prerequisite for the binding of Ecm29 to 
proteasomes. Since Ecm29, the extended α 7 tail, and the CK2 phosphorylation are found in human as well, this 
binding mechanism is likely conserved form yeast to humans. While this suggests that the interaction is regu-
lated by phosphorylation, the conditions leading to the dephosphorylation of α 7 and thus dynamic regulation of 
Ecm29 binding through phosphorylation remain to be identified.
Methods
Yeast techniques, plasmids and reagents. Yeast strains used are summarized in Table 1. Genomic 
manipulation of yeast was done using a PCR based approach65,66. Upon transformation of yeast, successful 
integration was confirmed by positive PCR for integration and negative PCR for wild type. To make α 7-Δ 40, primer 
pRL207: 5′ -TGC TAC AGG AAG CTA TCG ATT TTG CCC AAA AAG AAA TTA ACT GAG GCG CGC CAC 
TTC T-3′ and pRL66: 5′ -TCA ACT CTT TGG TTC TTC TTA ACG TAT TAT CAG AAT GTC ATC GAT GAA 
TTC GAG CTC G-3′ were used. α 7-Δ 19 that contains the acidic patch and phosphorylation sites, primers pRL 
248: 5′-TGA CAG TGA TAA CGT CAT GTC CAG TGA TGA TGA AAAT GCT TGA GGC GCG CCA CTT CT-3′ 
and pRL66, for α 7-Δ 19 (S/A) that replaces three Serine to Alanine (S258A, S263A and S264A) from α 7 tail 
Figure 6. Structural changes in the 26 S proteasome at the Ecm29 binding region. Three different 
conformations of the mature proteasome61 (4CR2, 4CR3, and CR4) were aligned in Pymol using the α 7 domain. 
The intermediate state (S2, 4CR3) is depicted in transparent gray, for the other states, S1 (4CR2) and S3 (4CR4) 
only the α 7 and Rpt5 subunits are depicted in color. The red residues in α 7 show the last three resolved residues 
(245-247; EIN), the phosphorylated residues that are important for Ecm29 binding extend from here, but are 
not resolved. Ecm29 also binds to Rpt5, but the precise site has not been mapped.
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pRL319: 5′ -ATC GAT TTT GCC CAA AAA GAA ATT AAC GGC GAT GAT GAC GAG GAC GAA GAT GAC 
GCG GAT AAC GTC ATG GCG GCC GAT GAT GAA AAT GCT TGA GGC GCG CCA CTT CT-3′ and pRL 
66 were used. To make α 7-Δ 19 (S/D) that represents the phospho mimic (S258D, S263D and S264D), pRL320: 
5′ -ATC GAT TTT GCC CAA AAA GAA ATT AAC GGC GAT GAT GAC GAG GAC GAAG ATG ACG ACG 
Strain Genotype Figure Ref.
sUB61 MAT α lys2-801 leu2-3, 2-112 ura3-52 his3-Δ 200 trp1-1 3a–c, 4a–d, 68
sDL135 MAT α pre1::PRE1-TEV-ProA (HIS3) 2b, 2d 13 (a)
sDL133 MAT α rpn11::RPN11-TEV-ProA (HIS3) 2b–c, 5b–d 69
sMK141 MAT α ecm29::TRP 3a–c, 14
sJR 211




sJR544 MAT α ecm29::TRP rpt5::RPT5Δ 3 (HYG) 3a–c 23
sJR552




sJR556 MAT A rpt5::RPT5Δ 3 (HYG) 3a–c, 4c–d, 23
sJR768 MAT α pre10::PRE10Δ 40 (KAN) 3a–c, 4a–b (a,b)
sJR770




sJR805 MAT A pre10::PRE10Δ 40 (KAN) rpt5::RPT5Δ 3 (HYG) 3a–c, (a,b)
sJR810




sJR816 MAT A ecm29:: pADH-H7-MYC-ECM29 (NAT) 4c–d (b)
sJR820





MAT α ecm29::TRP 
pre10::PRE10Δ 40 (KAN) 
rpn11::RPN11-TEVPro (HIS3)
6a (a,b)
sJR839 MAT A ecm29:: pGPD-H7-MYC-ECM29 (NAT) 4a–b (b)
sJR840




sJR856 MAT A ump1Δ pre10::PRE10Δ 40 (HIS3) 3a–c, 4a–d (b)*
sJR884















MAT α pre10::PRE10Δ 





MAT α pre10::PRE10Δ 19 




ump1Δ MAT A ump1Δ 3a–c, 4a–d 70*
Ump1-TAP MAT A ump1::UMP1-CBP-TEV-ZZ- (His3MX6) 6b *
Table 1.  Strains used in this study. * In the BY4741 background (MAT α his3Δ 1 leu2Δ 0 met15Δ 0 ura3Δ 0).  
aPRE1 encodes for the proteasome subunit β 4 and PRE10 for α 7. bThis study. All strains have background 
genotype (lys2-801 leu2-3, 2-112 ura3-52 his3-Δ200 trp1-1), with the exception of the ump1 manipulated 
strains indicated with* .
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ATA ACG TCA TGG ATG ACG ATG ATG AAA ATG CTT GAG GCG CGC CAC TTC T-3′ and pRL66 were 
used. All truncations and point mutations were confirmed by PCR followed by sequencing. To delete C-terminal 
last three amino acids from Rpt5 subunit, pRLS2-Rpt5: 5′ -AAT ATG TAG ATA TGT GAA TGG CGG CTT 
GAT AAA TCA AAA TAT TAT TAT TTA TCG ATG AAT TCG AGC TCG-3′ and pRLS3-Rpt5-Δ 3: 5′ -TCG 
TTG AGG GTA TAA GTG AAG TTC AAG CAA GAA AAT CGA AAT CGG TAT CCT AGG GCG CGC CAG 
ATC TGT T-3′ were used. The templates used for the PCR reactions indicated above were pFA61-3HA-kanMX6 
(KAN) and pYM24 (HYGRO), primers were designed to eliminate the 3-HA tags.
Ecm29 promoter changes were done by using pRL194: 5′ -TCT CCA CGA GCT GTT TTT CTT TCG CTT 
CGT CAG AAG AAA TGG A TC CGG AAT GGT GAT GGT GAT GGT GGT GCA TCG ATG AAT TCT CTG 
TCG-3′ and pfEcm29 Ntag s1: 5′ -CAA TAA TTA TAG AAA AGT TTC TAT TTC ACC ACG AAC AAC ATT 
CGT ACG CTG CAG GTC GAC-3′ with pYM-N15 to add GPD overexpression promoter. To add ADH weak 
expression promoter to Ecm29, pYM-N7 was used with pRL194 and pfEcm29-Ntag-s1. Integrations, truncations 
and mutations were confirmed by PCR and sequencing.
Antibodies used for immunoblots. Ecm29 and Rpn8 were detected using polyclonal antibody (generous 
gift by Dan Finley, Harvard Medical School, Boston, MA). Anti-α 7 monoclonal antibody and anti-Blm10 poly 
clonal antibody were purchased from Enzo Life Sciences and anti-Pgk1 monoclonal antibody was purchased 
from Invitrogen. Peroxidase-conjugated secondary antibodies were purchased from Jackson Immunoresearch 
Laboratories.
Proteasome purification. Specific yeast strains were grown overnight in 2 to 3 liter of YPD media (final 
A600 ~ 10.0). Cells were collected and washed with H2O. Pellets were resuspended in 1.5 pellet volume of lysis 
buffer (50 mM Tris [pH8.0], 5 mM MgCl2, 1 mM EDTA, and 1 mM ATP) and lyzed using a French Press at 1200 
Psi. Lysates were cleared by centrifugation (10,000 g; 30 minutes) and the supernatant was filtered through cheese-
cloth. Concentration of cell lysate was measured using NanoDrop 2000 Spectrophotometer using the Protein 
A280 program and cell lysate equivalent to 50 μ g of protein was boiled with 1X SDS-PAGE sample buffer for 
5 minutes at 96 °C. Next, samples were resolved on 11% SDS-PAGE. For proteasome purification cell lysate were 
filtered through cheesecloth prior to incubation with IgG beads (MP Biomedical; 0.75 ml resin bed volume per 25 
gram of cell pellet). After 1 hour of incubation (rotating at 4 °C), IgG beads were collected in an Econo Column 
(Bio-Rad) and washed with 50 bed volumes of ice-cold wash buffer (50 mM Tris [pH 7.5], 5 mM MgCl2, 50 mM 
NaCl, 1 mM EDTA, 1 mM ATP). Next, material was washed with 20 bed volumes of cleavage buffer (50 mM Tris 
[pH 7.5], 5 mM MgCl2, 1 mM DTT, and 1 mM ATP). Bead-bound proteasome complex was eluted by incubation 
with His-Tev protease (Invitrogen). The protease was removed by incubation with talon resin (Goldbio) prior to 
concentrating the proteasome complexes using 100 kDa concentrator (PALL Life Sciences). Purified proteasome 
were resolved on SDS-PAGE or on native gel as described previously67. To store samples, 5% final concentration 
glycerol was added and samples were stored at − 80 °C.
For core particle purification proteasome bound IgG beads were incubated with 5 bed volumes of wash buffer 
containing 500 mM NaCl for 1 hr at 4 °C under constant rotation. After incubation, the beads were washed with 
50 bed volumes of wash buffer with 500 mM NaCl. Elution and concentration of core particle complexes were as 
described above for proteasome complexes.
Yeast phenotypes. Indicated strains were incubated in 3 ml of YPD for overnight at 30 °C. Next day, cells 
equivalent to 1.0 at OD600 were collected and washed with 100 μ l sterile water. Cell pellet is then resuspended in 
133 μ l of sterile water and 4-fold serial dilutions were made in sterile water in 96 well plate. Diluted cells were then 
spotted on the indicated plates and incubated at indicated temperatures. Growth was monitored for 3 days on 
YPD plates and for 5–6 days on synthetic media plates.
Fluorescent phospho- and Coomassie Blue staining. 10 μ g Proteasome complex purified from the 
indicated samples were mixed with the 6X loading buffer and boiled for 5 minutes at 95 °C. Boiled samples were 
cooled to room temperature and resolved on 11% SDS-PAGE gel. To detect the phosphorylated proteins, gel 
was subjected to fluorescent photo staining by using ProQ Diamond Phosphoprotein Gel Stain according to the 
manufacturer’s recommendations (Life Technologies) and scanned with a Typhoon-9410 imager from Amersham 
Biosciences (excitation at 532 nm and an emission filter of 560 nm longpass). After destaining, the gel was treated 
with Coomassie Blue and imaged using a Gbox image system (SynGene) with GeneSnap software.
Apyrase assay. Proteasome purified from the indicated strains were inhibited using 200 nM of Epoxomicin 
at 30 °C for 30 minutes. Both inhibited and non-inhibited proteasome samples are then subjected to apyrase 
treatment for 45 minutes at 30 °C by adding apyrase (Sigma) at a final concentration of 20 mU/μ l in buffer (50 mM 
Tris-HCl [pH 7.5], 5 mM MgCl2, 0.25 mM ATP). Samples are then analyzed on native gels followed by in-gel 
activity assay using LLVY-AMC as substarte. Next, protein resolved in gel were transfered to pvdf membrane as 
described previously and used for immunoblotting14.
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